TI
ABBV icon

Tidal Investments’s AbbVie ABBV Stock Holding History

Tidal Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
+2,000
New +$430K ﹤0.01% 2096
2026
Q1 		– Sell
-1,100
Closed -$251K – 2336
2025
Q4 		$251K Buy
+1,100
New +$251K ﹤0.01% 1918
2025
Q1 		– Sell
-2
Closed -$10 – 1825
2024
Q4 		$10 Buy
+2
New +$368 ﹤0.01% 1846

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tidal Investments's ABBV Position: Q2 2026 in Review

Tidal Investments increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $18.9M and bringing the position to 585,879 shares worth $147M. The position accounts for 0.26% of the portfolio, ranked #75.

Tidal Investments first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tidal Investments held 585,879 shares of AbbVie worth $147M as of Q2 2026.
  • Tidal Investments bought 87,932 AbbVie shares in Q2 2026, an estimated $18.9M.
  • AbbVie made up 0.26% of Tidal Investments's portfolio in Q2 2026, its #75 holding.
  • Tidal Investments first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.